Recombinant Acinetobacter sp. 50S ribosomal protein L16 (rplP) is a synthesized protein derived from Acinetobacter species, mirroring the naturally occurring 50S ribosomal protein L16 . Ribosomal proteins, like L16, are essential components of ribosomes, which are responsible for protein synthesis in cells . The "50S" refers to the larger subunit of the bacterial ribosome, and L16 is one of the many proteins that constitute this subunit.
The recombinant form of this protein is produced using genetic engineering techniques, typically in a host organism like Escherichia coli, to generate large quantities of the protein for research or other applications . The rplP gene encodes the ribosomal protein L16 .
The primary function of the 50S ribosomal protein L16 is its involvement in protein synthesis . Ribosomes, composed of 30S and 50S subunits in bacteria, are the sites where mRNA is translated into proteins. L16, as a component of the 50S subunit, plays a critical role in the structural integrity and functional activity of the ribosome.
Antimicrobial Discovery: Ribosomal proteins are increasingly studied as potential targets for new antimicrobials . The rationale is that by disrupting the bacterial ribosome's function, it's possible to inhibit protein synthesis and, thus, bacterial growth.
Resistance Mechanisms: Research indicates that the expression of ribosomal proteins, including L16, can be altered in response to antibiotic exposure . For example, increased expression of ribosomal proteins has been observed in Acinetobacter strains that have developed resistance to antibiotics like eravacycline.
Basic Research: Recombinant L16 is used in structural and functional studies of ribosomes . These studies aim to elucidate the precise mechanisms of protein synthesis and how ribosomes interact with various factors and antibiotics.
Vaccine Development: Ribosomal proteins have been explored as potential vaccine candidates . Their conserved nature and essential function make them attractive targets for eliciting broad-spectrum immunity.
The up-regulation of ribosomal proteins is associated with antibiotic resistance in Acinetobacter strains . In Acinetobacter strains resistant to eravacycline, experiments have revealed increased expression of ribosomal proteins. This suggests that changes in ribosomal protein expression can be a mechanism by which bacteria adapt and survive in the presence of antibiotics.
Gene Sequencing: Utilizing techniques like 16S rRNA sequencing to identify and differentiate closely related bacterial species, which is crucial in studies involving Acinetobacter .
Proteomic Analysis: Employing mass spectrometry to quantify protein levels in mutant strains, which helps in understanding the impact of metabolic disruptions on ribosomal protein levels .
Heterologous Expression: Refactoring biosynthetic gene clusters in organisms like E. coli to produce and study modified peptides and their antimicrobial activities .
qRT-PCR Analysis: Quantifying gene expression changes in response to antibiotic induction, providing insights into resistance mechanisms .
In silico structural modeling: predicting protein structure and function through computational methods based on sequence data.
KEGG: aci:ACIAD3212
STRING: 62977.ACIAD3212
The 50S ribosomal protein L16 (rplP) is a critical component of the large ribosomal subunit in Acinetobacter species. It plays essential roles in ribosomal assembly, stability, and protein synthesis functionality. In Acinetobacter, rplP contributes to the peptidyltransferase center formation, which is crucial for the catalytic activity of the ribosome during protein synthesis. Understanding this protein is particularly important given that Acinetobacter species, especially A. baumannii, are known for their multidrug resistance mechanisms and pathogenicity .
Methodologically, researchers can investigate rplP function through:
Genetic knockout studies with complementation assays
Site-directed mutagenesis targeting conserved residues
Ribosome profiling to assess translation efficiency
Structural studies using cryo-electron microscopy
Identification and characterization of rplP genes across Acinetobacter strains require a combination of genomic and molecular approaches. PCR amplification using specific primers can effectively detect the gene in various isolates. For instance, researchers can adapt approaches similar to those used for 16S rRNA amplification in Acinetobacter species .
For thorough characterization:
Design degenerate primers targeting conserved regions of rplP based on alignments of known sequences
Perform PCR amplification followed by sequencing verification
Conduct multiple sequence alignment to identify conserved and variable regions
Analyze phylogenetic relationships to determine evolutionary patterns
This methodological approach can be particularly valuable when investigating Acinetobacter species with variable antibiotic resistance profiles, as observed in multidrug-resistant clinical isolates .
When studying rplP expression across varying growth conditions in Acinetobacter species, researchers should employ multiple complementary techniques to ensure robust results:
| Technique | Application | Advantages | Limitations |
|---|---|---|---|
| RT-qPCR | mRNA quantification | High sensitivity, relative quantification | Requires stable reference genes |
| Western Blotting | Protein level detection | Direct protein measurement | Requires specific antibodies |
| RNA-Seq | Transcriptome-wide expression | Comprehensive view, identifies co-regulated genes | Computationally intensive analysis |
| Ribosome Profiling | Translation efficiency | Measures actual translation | Technically demanding |
| Proteomics (LC-MS/MS) | Protein abundance and modifications | Identifies post-translational modifications | Expensive, complex sample preparation |
For optimal results, researchers should normalize expression data against multiple housekeeping genes and validate findings using at least two independent methods. This approach is particularly important when studying Acinetobacter under antibiotic stress conditions that might affect global translation machinery .
Mutations in the rplP gene can significantly contribute to antibiotic resistance in A. baumannii through several mechanisms. Ribosomal proteins, including L16, are targets for various antibiotics that inhibit protein synthesis. Specific mutations in rplP may alter the binding sites for these antibiotics, reducing their efficacy.
The research methodology to investigate this relationship includes:
Whole genome sequencing of resistant isolates to identify rplP mutations
Site-directed mutagenesis to introduce specific mutations
Minimum inhibitory concentration (MIC) determination to assess resistance levels
Structural modeling to predict how mutations affect antibiotic binding
In vitro translation assays to directly measure the impact on protein synthesis
Studies on multidrug-resistant A. baumannii have demonstrated that numerous resistance genes can coexist within a single isolate, creating complex resistance profiles . When investigating rplP mutations, researchers should consider this genetic complexity and potential interactions between different resistance mechanisms.
Expression and purification of recombinant Acinetobacter rplP for structural studies present several challenges related to its intrinsic properties:
| Challenge | Cause | Methodological Solution |
|---|---|---|
| Protein aggregation | Hydrophobic regions that interact with rRNA/proteins | Use solubility tags (MBP, SUMO); optimize buffer conditions |
| Low expression yield | Codon bias between Acinetobacter and expression host | Codon optimization; use specialized expression strains |
| Structural instability | Absence of binding partners from 50S subunit | Co-expression with interacting partners; addition of stabilizing agents |
| Improper folding | Chaperone dependency in native context | Expression at lower temperatures; co-expression with chaperones |
| Toxicity to host cells | Interference with host translation machinery | Use inducible expression systems; tightly controlled promoters |
To overcome these challenges, researchers should:
Screen multiple expression systems (E. coli, yeast, insect cells)
Optimize induction conditions (temperature, inducer concentration, duration)
Test various purification strategies (affinity, ion-exchange, size-exclusion chromatography)
Consider protein engineering approaches to improve stability
These methodological considerations are particularly important given the significant sequence variations observed between different Acinetobacter strains, as has been documented in genomic surveillance studies .
Cryo-electron microscopy (cryo-EM) offers powerful capabilities for studying ribosome assembly and the specific role of rplP in Acinetobacter species. Optimizing cryo-EM approaches involves several methodological considerations:
Sample Preparation Optimization:
Isolate ribosomes at different assembly stages to capture intermediates
Use rplP depletion strains to examine assembly defects
Apply gradient purification to separate assembly intermediates
Optimize buffer conditions to maintain native conformations
Data Collection Strategies:
Implement time-resolved cryo-EM to capture dynamic assembly processes
Use direct electron detectors with high detective quantum efficiency
Apply energy filters to improve contrast
Collect tilt series to address preferred orientation issues
Image Processing Workflow:
Employ 3D classification to identify assembly intermediates
Use focused classification on the rplP binding region
Implement multi-body refinement to analyze flexible regions
Apply symmetry-relaxed reconstruction for asymmetric intermediates
Validation and Interpretation:
Correlate structural findings with biochemical assembly assays
Perform cross-linking mass spectrometry to validate protein-protein interactions
Use genetic approaches to verify the functional significance of structural findings
This methodological framework provides a comprehensive approach to visualizing and understanding how rplP contributes to ribosome assembly in Acinetobacter, which may have implications for understanding antibiotic resistance mechanisms .
Selecting the appropriate expression system for recombinant Acinetobacter rplP requires careful consideration of protein functionality and yield requirements:
| Expression System | Advantages | Disadvantages | Best Applications |
|---|---|---|---|
| E. coli BL21(DE3) | High yield, simple protocols | Potential inclusion body formation | Initial screening, structural studies |
| E. coli Rosetta | Addresses codon bias issues | Higher cost | Expression of proteins with rare codons |
| E. coli ArcticExpress | Better folding at low temperatures | Slower growth, lower yields | Proteins prone to misfolding |
| Yeast (P. pastoris) | Post-translational modifications | Longer development time | Functional studies requiring modifications |
| Insect cell (Sf9) | Complex folding support | Expensive, time-consuming | Interaction studies with ribosomal partners |
| Cell-free systems | Avoids toxicity issues | Lower yield, expensive | Rapid screening, toxic proteins |
Methodological recommendations:
Begin with a parallel screening approach using multiple expression systems
Test various fusion tags (His, GST, MBP, SUMO) for improved solubility
Optimize induction parameters (temperature, inducer concentration, time)
Evaluate functionality using in vitro translation assays
Confirm structural integrity through circular dichroism or limited proteolysis
When designing expression constructs, consider that Acinetobacter species often have unique codon usage patterns that may affect heterologous expression efficiency, as observed in genomic analyses of various Acinetobacter strains .
Investigating rplP interactions with antibiotics in multidrug-resistant Acinetobacter requires a multi-faceted experimental approach:
Binding Studies:
Surface plasmon resonance (SPR) to determine binding kinetics
Isothermal titration calorimetry (ITC) to measure thermodynamic parameters
Fluorescence-based assays for high-throughput screening
Hydrogen-deuterium exchange mass spectrometry to map binding interfaces
Functional Assays:
In vitro translation systems using purified components
Toe-printing assays to assess ribosomal positioning
Ribosome profiling to measure translation efficiency in vivo
Growth inhibition assays with antibiotic concentration gradients
Structural Approaches:
Cryo-EM of ribosome-antibiotic complexes
X-ray crystallography of rplP domains with bound antibiotics
Molecular dynamics simulations to predict binding site flexibility
Site-directed mutagenesis to validate key interaction residues
Resistance Mechanism Investigation:
Comparative studies between sensitive and resistant strains
Directed evolution experiments to identify resistance-conferring mutations
Gene replacement studies to confirm causative mutations
Transcriptomics to identify compensatory mechanisms
These methodological approaches should consider the complex genetic background of multidrug-resistant Acinetobacter strains, which often carry multiple resistance determinants. Studies have shown that clinical isolates can harbor more than eight identified resistance determinants, creating complex resistance profiles .
| Control Type | Purpose | Implementation |
|---|---|---|
| Wild-type strain | Establish baseline phenotype | Use isogenic parent strain |
| Complemented mutant | Verify phenotype is due to rplP mutation | Express wild-type rplP from plasmid in mutant |
| Unrelated gene mutant | Control for general effects of genetic manipulation | Create mutation in non-ribosomal gene |
| Growth controls | Account for growth rate differences | Normalize data to growth parameters |
| Media controls | Control for environmental effects | Test multiple media conditions |
| In vivo controls | Account for host factors | Include mock-infected animals/cells |
| Technical controls | Control for experimental variation | Include technical replicates |
| Biological controls | Account for strain-specific effects | Test multiple clinical isolates |
Essential methodological approaches:
Generate clean deletion mutants using allelic exchange to avoid polar effects
Confirm mutations by whole genome sequencing to identify potential compensatory mutations
Measure fitness parameters (growth rate, competition assays) under multiple conditions
Assess virulence using multiple models (cell culture, invertebrate, vertebrate)
Quantify ribosome function using polysome profiling and translation efficiency assays
These controls are particularly important considering that Acinetobacter baumannii carries multiple virulence factors that contribute to pathogenesis, as highlighted in microbiological studies .
Contradictory findings regarding rplP function across Acinetobacter species are not uncommon and require systematic approaches to reconcile:
Standardization of Experimental Conditions:
Establish consistent growth conditions, media compositions, and physiological states
Standardize protein expression and purification protocols
Use identical assay systems across different species
Implement unified data collection and analysis pipelines
Comparative Genomics Approach:
Conduct comprehensive sequence alignments of rplP across species
Identify species-specific amino acid substitutions that might explain functional differences
Analyze genomic context and operon structure around rplP
Examine evolutionary relationships through phylogenetic analysis
Integrative Data Analysis:
Perform meta-analysis of published results with standardized effect size calculations
Use Bayesian statistical approaches to integrate heterogeneous datasets
Apply systems biology modeling to contextualize rplP within the broader cellular network
Develop predictive models that account for species-specific variations
Experimental Validation:
Design chimeric rplP proteins to identify functionally divergent domains
Perform cross-species complementation studies
Conduct site-directed mutagenesis to convert residues between species
Use heterologous expression systems to assess functional conservation
These methodological approaches acknowledge the significant genetic diversity within Acinetobacter species. Studies have demonstrated that even within the same species, substantial phylogenetic diversity exists, as observed in genomic surveillance studies of Acinetobacter baumannii .
Predicting the impact of novel rplP mutations on antibiotic resistance requires sophisticated bioinformatic approaches:
| Bioinformatic Approach | Application | Advantages | Methodological Considerations |
|---|---|---|---|
| Homology Modeling | Predict structural changes | Fast, uses known structures | Accuracy depends on template similarity |
| Molecular Dynamics | Simulate antibiotic binding | Captures dynamic interactions | Computationally intensive |
| Machine Learning | Predict resistance phenotypes | Can integrate diverse data types | Requires large training datasets |
| Genome-Wide Association | Identify resistance-associated SNPs | Discovers novel associations | Needs many sequenced isolates |
| Evolutionary Analysis | Identify selection pressure | Detects adaptive mutations | Requires diverse temporal samples |
| Network Analysis | Predict epistatic interactions | Maps compensatory mutations | Complex to implement |
Recommended methodological workflow:
Start with sequence conservation analysis to identify potentially important residues
Perform structural prediction using homology modeling based on available ribosome structures
Conduct molecular docking simulations with relevant antibiotics
Validate predictions with experimental MIC determinations
Iterate the model using measured resistance phenotypes
This systematic approach can help predict resistance mechanisms, which is particularly valuable given the complex resistance profiles observed in multidrug-resistant Acinetobacter isolates . Studies have shown that Acinetobacter can harbor multiple resistance determinants that may interact in complex ways to produce the final resistance phenotype.
Interpreting changes in rplP expression during Acinetobacter adaptation to antibiotic stress requires a nuanced analytical framework:
Temporal Expression Analysis:
Measure expression at multiple time points following antibiotic exposure
Distinguish between immediate responses and adaptive changes
Determine if expression changes are sustained after antibiotic removal
Compare expression patterns across different antibiotic classes
Contextual Interpretation:
Analyze rplP expression in relation to other ribosomal proteins
Assess coordinated responses of translation-related genes
Examine expression in context of global stress responses
Consider potential regulatory network effects
Functional Consequences Assessment:
Correlate expression changes with translation efficiency
Measure impact on growth rate and fitness
Determine effects on antibiotic susceptibility
Assess influence on virulence factor expression
Statistical and Analytical Approaches:
Apply time-series analysis methods to capture expression dynamics
Use principal component analysis to identify major response patterns
Implement network analysis to identify co-regulated genes
Develop predictive models of adaptation based on expression profiles
This comprehensive analytical framework helps researchers distinguish between adaptive responses and non-specific stress reactions. Studies on carbapenem-resistant Acinetobacter baumannii have shown that adaptation to antibiotics involves complex genomic changes that can affect multiple cellular systems .
CRISPR-Cas9 technology offers powerful capabilities for studying rplP function in multidrug-resistant Acinetobacter, but requires optimization:
Delivery System Optimization:
Develop efficient electroporation protocols specific for Acinetobacter
Optimize conjugation-based transfer methods for clinical isolates
Design specialized delivery vectors with Acinetobacter-specific origins of replication
Implement transient expression systems to minimize off-target effects
Guide RNA Design Strategies:
Create species-specific algorithms for gRNA design in Acinetobacter
Target conserved regions to improve editing efficiency
Develop multiplexed gRNA systems for simultaneous editing of rplP and related genes
Implement machine learning approaches to predict off-target effects
Editing Strategy Selection:
For essential genes like rplP, use inducible CRISPR interference (CRISPRi) systems
Implement base editing for precise nucleotide substitutions without double-strand breaks
Design conditional knockout systems for temporal control of gene expression
Create scarless editing protocols to avoid polar effects on downstream genes
Validation and Phenotypic Analysis:
Implement whole genome sequencing to verify edits and detect off-target effects
Develop high-throughput screening methods to assess antibiotic susceptibility
Utilize ribosome profiling to directly measure functional impacts on translation
Apply comparative proteomics to assess global effects of rplP modifications
These methodological considerations are particularly important given the genetic complexity of multidrug-resistant Acinetobacter strains, which often harbor multiple resistance mechanisms requiring precise genetic manipulation approaches .
Targeting rplP for novel antibiotic development against Acinetobacter requires innovative approaches:
| Approach | Mechanism | Advantages | Methodological Considerations |
|---|---|---|---|
| Structure-Based Drug Design | Rational design based on rplP structure | Highly specific | Requires high-resolution structures |
| Fragment-Based Screening | Identify small molecule binders | Discovers novel scaffolds | Needs specialized screening assays |
| Peptide Mimetics | Mimic natural rplP interacting partners | High specificity | Delivery challenges |
| Antisense Oligonucleotides | Target rplP mRNA | Sequence-specific | Cellular uptake limitations |
| Ribosome Assembly Inhibitors | Block rplP incorporation | Novel mechanism | Complex screening requirements |
| Allosteric Modulators | Alter rplP function without direct binding | Overcome resistance | Difficult to design rationally |
Recommended methodological workflow:
Perform comparative structural analysis of rplP across bacterial species to identify Acinetobacter-specific features
Develop high-throughput screening assays specific for rplP function
Conduct virtual screening followed by experimental validation
Assess specificity against human ribosomal proteins to minimize toxicity
Evaluate activity against diverse clinical isolates
Test for resistance development through serial passage experiments
This targeted approach could address the urgent need for new antibiotics against multidrug-resistant Acinetobacter strains. Studies have shown that A. baumannii can develop resistance to multiple antibiotic classes through various mechanisms , highlighting the need for novel therapeutic strategies with distinct mechanisms of action.
The interaction dynamics between rplP and other ribosomal components in antibiotic-resistant versus susceptible Acinetobacter can be investigated through several methodological approaches:
Structural Comparative Analysis:
Perform cryo-EM of ribosomes from resistant and susceptible strains
Conduct hydrogen-deuterium exchange mass spectrometry to map interaction interfaces
Use chemical cross-linking followed by mass spectrometry to identify proximal proteins
Apply single-molecule FRET to measure dynamic interactions
Interaction Network Mapping:
Implement ribosome profiling to assess translation complex formation
Perform co-immunoprecipitation studies with tagged rplP variants
Utilize bacterial two-hybrid systems to screen for altered interactions
Apply proteome-wide thermal shift assays to detect stability changes
Functional Assessment:
Develop reconstituted in vitro translation systems with defined components
Measure kinetics of ribosome assembly with purified components
Assess antibiotic binding kinetics in reconstituted systems
Quantify translational fidelity using reporter systems
Computational Approaches:
Perform molecular dynamics simulations of ribosomal complexes
Use network analysis to identify altered interaction patterns
Apply machine learning to predict functional consequences of altered interactions
Develop mathematical models of ribosome assembly kinetics
These methodological approaches can provide insights into how antibiotic resistance mutations in rplP affect its interactions with other ribosomal components, potentially revealing new therapeutic targets. Studies on multidrug-resistant Acinetobacter have demonstrated that resistance can involve complex mechanisms affecting multiple cellular components .